The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease

Exp Neurol. 2010 Nov;226(1):120-7. doi: 10.1016/j.expneurol.2010.08.011. Epub 2010 Aug 14.


Local field potentials (LFPs) recorded through electrodes implanted in the subthalamic nucleus (STN) for deep brain stimulation (DBS) in patients with Parkinson's disease (PD) show that oscillations in the beta frequency range (8-20 Hz) decrease after levodopa intake. Whether and how DBS influences the beta oscillations and whether levodopa- and DBS-induced changes interact remains unclear. We examined the combined effect of levodopa and DBS on subthalamic beta LFP oscillations, recorded in nine patients with PD under four experimental conditions: without levodopa with DBS turned off; without levodopa with DBS turned on; with levodopa with DBS turned on; and with levodopa with DBS turned off. The analysis of STN-LFP oscillations showed that whereas levodopa abolished beta STN oscillations in all the patients (p=0.026), DBS significantly decreased the beta oscillation only in five of the nine patients studied (p=0.043). Another difference was that whereas levodopa completely suppressed beta oscillations, DBS merely decreased them. When we combined levodopa and DBS, the levodopa-induced beta disruption prevailed and combining levodopa and DBS induced no significant additive effect (p=0.500). Our observations suggest that levodopa and DBS both modulate LFP beta oscillations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Antiparkinson Agents / therapeutic use*
  • Beta Rhythm / drug effects*
  • Combined Modality Therapy
  • Data Interpretation, Statistical
  • Deep Brain Stimulation*
  • Female
  • Humans
  • Levodopa / therapeutic use*
  • Longitudinal Studies
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neurosurgical Procedures
  • Parkinson Disease / drug therapy
  • Parkinson Disease / surgery
  • Parkinson Disease / therapy*
  • Stereotaxic Techniques
  • Subthalamic Nucleus / physiopathology*
  • Tomography, X-Ray Computed


  • Antiparkinson Agents
  • Levodopa